Search

everythinglearnresearchcommunity

for

Search:↓

Poor response to topical immunotherapy in alopecia areata patients is linked to impaired cell responses.

A new classification for trichothiodystrophy helps identify genetic causes and potential treatments.

Targeting specific T cells may help treat alopecia areata.

Contact immunotherapy can change immune responses in alopecia areata, suggesting new treatment targets.

The buffy coat method yields higher TGF-β1 levels in PRP, especially in males.

Chronic graft-versus-host disease in the skin shows strong Th1 immune response and unique barrier issues.

Mitochondrial features can predict colorectal cancer outcomes and improve immunotherapy.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Skin-resident memory T cells may contribute to chronic alopecia areata and baricitinib could be a potential treatment.

Alopecia areata patients show unique protein activity patterns, suggesting imbalanced signaling pathways.

In alopecia areata, certain immune cells increase and express a protein linked to immune activation.

The combination therapy was effective and well-tolerated, especially in young patients.

T cells with memory features grow in number and gather around hair follicles when there are not enough immune cells.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Tgm2 helps stabilize dying cells and aids fibroblast attachment to the extracellular matrix.

Super-enhancers control CD25 expression in specific cell types, affecting immune function.

New findings suggest targeting IL-23 could treat psoriasis, skin cells can adapt to new roles, direct conversion of skin cells to blood cells may aid cell therapy, removing certain tumor cells could boost cancer immunotherapy, and melanoma may have many tumorigenic cells, not just cancer stem cells.

HPV8 E6 gene causes growth of certain skin stem cells.

Interferon, especially alfa interferon, is an effective treatment for cutaneous T-cell lymphoma with manageable side effects.

Ki-67 levels do not predict treatment response in triple-negative breast cancer.

B cells can both help and hinder the body's defense against melanoma.

Certain blood cell ratios are higher in kids with alopecia areata and might help predict the disease.

Higher levels of certain immune cells and proteins are linked to more severe lupus symptoms.

Neutropenic patients show significant changes in immune cell types and lower neutrophil and natural killer cell percentages.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

The CD44-CD49d complex boosts T cell activation and survival in autoimmune disease.

Using CD123 to detect certain immune cells helps diagnose a type of hair loss condition.

CD98hc's role in skin health decreases with age.

CD133+ progenitor cells have therapeutic potential for diabetic ulcers and heart attack recovery, with manageable risks.

A man got six skin cancers within a year after a cell transplant for leukemia but was cancer-free 32 months later; skin checks are important post-transplant.